Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03333577 · ClinicalTrials.gov registry record · NA
Evaluation of the Baha SoundArc in Pediatric Patients
A NA study, sponsored by Cochlear.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
NCT03333577: Completed NA study, sponsored by Cochlear.
NCT03333577 is a NA study that has completed, run by Cochlear. The registered enrollment target is 32 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03333577, a NA study, has completed, sponsored by Cochlear.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
Study Summary
The purpose of this study is to gather clinical performance data on the Baha SoundArc
Primary Outcome
To evaluate patient experience when using the Baha SoundArc after a one month take-home trial, compared to the existing Baha Softband on the Participant Take Home questionnaire (strongly agree, Agree, Neutral, disagree, strongly disagree)
Interventions
- DEVICE SoundArc
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2017-11-02 |
| Est. Completion | 2018-11-02 |
| Phase | NA |
What the finished NCT03333577 record still lists
NCT03333577 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which SoundArc is the first listed.
NCT03333577 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03333577 about?
NCT03333577 is a clinical study titled "Evaluation of the Baha SoundArc in Pediatric Patients". The purpose of this study is to gather clinical performance data on the Baha SoundArc
What is the current status of trial NCT03333577?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2017-11-02. Estimated completion is 2018-11-02.
What interventions are being tested in trial NCT03333577?
The interventions under investigation include: SoundArc (DEVICE).
Who is sponsoring clinical trial NCT03333577?
This trial is sponsored by Cochlear, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03333577's enrollment target sits among peer trials
32 1578th of 2000 higher than 409 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI